British Scandal Listen Now: Business Wars | The Race to Ozempic
5 snips
Nov 19, 2025 Explore the thrilling race to dominate the weight-loss drug market with Ozempic. Discover the shocking FDA raid uncovering thousands of illegal shipments of semaglutide. Learn about the dangerous spread of counterfeit drugs that jeopardize public safety. Delve into Novo Nordisk's fierce battle to protect its groundbreaking medication while facing competition from Eli Lilly in a staggering $28 billion market. This high-stakes business drama reveals the lengths companies go to win the pharmaceutical war.
AI Snips
Chapters
Transcript
Episode notes
Surging Demand Created A Supply Crisis
- Ozempic's rapid popularity spurred massive demand that outstripped supply.
- That shortage pushed consumers toward dangerous unregulated alternatives and intensified competition between drugmakers.
Major FDA Raid On Fake Drug Shipment
- FDA agents raided a Cincinnati shipping yard and found thousands of vials labeled semaglutide in containers from Hong Kong.
- They seized about 17,000 unregulated vials worth millions, highlighting extensive illegal distribution networks.
Counterfeits Threaten Safety And Brand Integrity
- Counterfeit semaglutide vials flood the U.S. market and may not contain the active ingredient.
- Novo Nordisk and the FDA see these knockoffs as both a public-safety threat and a challenge to the drug's integrity.